Raymond James Financial Inc. Invests $17.16 Million in Mirion Technologies, Inc. (NYSE:MIR)

Raymond James Financial Inc. bought a new position in shares of Mirion Technologies, Inc. (NYSE:MIR - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 983,610 shares of the company's stock, valued at approximately $17,164,000. Raymond James Financial Inc. owned about 0.42% of Mirion Technologies as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Quest Partners LLC lifted its position in shares of Mirion Technologies by 680.5% during the 3rd quarter. Quest Partners LLC now owns 6,728 shares of the company's stock worth $74,000 after buying an additional 5,866 shares during the last quarter. US Bancorp DE boosted its stake in Mirion Technologies by 3,248.7% in the fourth quarter. US Bancorp DE now owns 6,262 shares of the company's stock valued at $109,000 after acquiring an additional 6,075 shares in the last quarter. SkyView Investment Advisors LLC purchased a new position in shares of Mirion Technologies during the third quarter worth about $111,000. Paloma Partners Management Co purchased a new stake in shares of Mirion Technologies in the 3rd quarter valued at about $122,000. Finally, KBC Group NV boosted its position in shares of Mirion Technologies by 39.2% in the 4th quarter. KBC Group NV now owns 8,002 shares of the company's stock valued at $140,000 after purchasing an additional 2,254 shares during the period. 78.51% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on MIR shares. The Goldman Sachs Group increased their price objective on Mirion Technologies from $16.00 to $21.00 and gave the company a "buy" rating in a report on Thursday, December 12th. Baird R W raised Mirion Technologies to a "strong-buy" rating in a research note on Thursday, December 19th. Citigroup lifted their target price on Mirion Technologies from $18.00 to $20.00 and gave the company a "buy" rating in a research note on Wednesday, December 4th. Finally, Robert W. Baird assumed coverage on Mirion Technologies in a research note on Thursday, December 19th. They set an "outperform" rating and a $22.00 price target for the company. Three analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Buy" and an average price target of $19.25.

Remove Ads

Mirion Technologies Price Performance

Shares of Mirion Technologies stock traded down $0.00 during trading on Friday, reaching $15.22. The company's stock had a trading volume of 3,029,429 shares, compared to its average volume of 1,591,153. The business has a 50 day moving average price of $15.71 and a 200-day moving average price of $14.90. The company has a market capitalization of $3.54 billion, a P/E ratio of -80.10 and a beta of 0.74. The company has a quick ratio of 1.55, a current ratio of 2.16 and a debt-to-equity ratio of 0.43. Mirion Technologies, Inc. has a 12-month low of $9.11 and a 12-month high of $18.81.

Mirion Technologies (NYSE:MIR - Get Free Report) last announced its quarterly earnings results on Tuesday, February 11th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.14 by $0.02. Mirion Technologies had a negative net margin of 4.21% and a positive return on equity of 4.78%. As a group, sell-side analysts anticipate that Mirion Technologies, Inc. will post 0.39 EPS for the current year.

About Mirion Technologies

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.